JNJ
Johnson & Johnson
NYSE: JNJ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$229.85
+1.10% today
Updated 2026-04-30
Market cap
$547.28B
P/E ratio
26.31
P/S ratio
5.68x
EPS (TTM)
$8.64
Dividend yield
2.28%
52W range
$142 – $252
Volume
8.0M
Johnson & Johnson (JNJ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $14.25B | $15.25B | $14.97B | $16.57B | $16.39B | $14.30B | $15.40B | $17.41B | $18.47B | $19.28B | $18.77B | $21.06B | $22.20B | $23.42B | $23.54B | $23.41B | $21.19B | $22.79B | $24.27B | $24.53B |
| Capital expenditures | $2.74B | $3.31B | $3.07B | $2.37B | $2.38B | $2.89B | $2.93B | $3.60B | $3.71B | $3.46B | $3.23B | $3.28B | $3.67B | $3.50B | $3.35B | $3.65B | $4.01B | $4.54B | $4.42B | $4.83B |
| Depreciation | $2.18B | $2.78B | $2.83B | $2.77B | $2.94B | $3.16B | $3.67B | $4.10B | $3.90B | $3.75B | $3.75B | $5.64B | $6.93B | $7.01B | $7.23B | $7.39B | $6.97B | $7.49B | $7.34B | $7.50B |
| Stock-based comp | $559.00M | $698.00M | $627.00M | $628.00M | $614.00M | $621.00M | $662.00M | $728.00M | $792.00M | $874.00M | $878.00M | $962.00M | $978.00M | $977.00M | $1.00B | $1.14B | $1.14B | $1.16B | $1.18B | $1.35B |
| Free cash flow | $11.51B | $11.94B | $11.91B | $14.21B | $14.00B | $11.40B | $12.46B | $13.82B | $14.76B | $15.82B | $15.54B | $17.78B | $18.53B | $19.92B | $20.19B | $19.76B | $17.18B | $18.25B | $19.84B | $19.70B |
| Investing cash flow | $-20.29B | $-6.14B | $-4.19B | $-7.60B | $-7.85B | $-4.61B | $-4.51B | $-5.10B | $-12.30B | $-7.74B | $-4.76B | $-14.87B | $-3.17B | $-6.19B | $-20.82B | $-8.68B | $-12.37B | $878.00M | $-18.60B | $-23.59B |
| Financing cash flow | $-6.11B | $-5.70B | $-7.46B | $-4.09B | $-4.98B | $-4.45B | $-20.56B | $-6.09B | $-12.26B | $-10.85B | $-8.55B | $-7.67B | $-18.51B | $-18.02B | $-6.12B | $-14.05B | $-8.87B | $-15.82B | $-3.13B | $-5.54B |
| Dividends paid | $4.27B | $4.67B | $5.02B | $5.33B | $5.80B | $6.16B | $6.61B | $7.29B | $7.77B | $8.17B | $8.62B | $8.94B | $9.49B | $9.92B | $10.48B | $11.03B | $11.68B | $11.77B | $11.82B | $12.38B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $5.04B | $3.54B | $5.19B | $-9.63B | $6.02B | $-6.40B | $-791.00M | $5.24B | $-1.15B | $283.00M | $-793.00M | $-3.41B | $680.00M | $-48.00M | — | — | — |